title: Bevacizumab alone or in combination with chemotherapy in glioblastomas?--authors' reply.
authors.affiliation: Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands. Electronic address: m.vandenbent@erasmusmc.nl.
authors.forename: Martin J
authors.initials: MJ
authors.lastname: van den Bent
authors.affiliation: Department of Neuro-Oncology, Erasmus MC Cancer Institute, Rotterdam, Netherlands.
authors.forename: Walter
authors.initials: W
authors.lastname: Taal
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000008:administration & dosage*; D001932:Brain Neoplasms / Q000628:therapy*; D005260:Female; D005909:Glioblastoma / Q000628:therapy*; D006801:Humans; D008130:Lomustine / Q000008:administration & dosage*; D008297:Male; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy* / Q000401:mortality*
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D008130:Lomustine